NEW

American College of Surgeons Recognizes ChristianaCare for ‘Meritorious’ Surgical Outcomes for 9th Consecutive Year

ChristianaCare has been honored as one of only 89 institutions out of 722 by the American College of Surgeons (ACS) Clinical Congress for achieving “meritorious” outcomes in surgical patient care.

Aspen Surgical Acquires Protek Medical Products

Aspen Surgical Products Inc. has announced its acquisition of Protek Medical Products Inc. Based in Coralville, Iowa, Protek is a global manufacturer of single-use ultrasonic probe covers and needle guides used in tissue biopsies, fluid aspiration and vascular access...

Exactech Sharpens Focus on Technology with Active Intelligence

Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, has announced the launch of its Active Intelligence® platform of technologies that spans the entire journey of patient care.

New BioPledge Bleach And Alcohol-Free Daily Disinfectant Approved By EPA For Use Against COVID-19 Virus

BioPledge LLC announced today the U. S. Environmental Protection Agency (EPA) approval of BioPledge® Antimicrobial POWER™ healthcare disinfectant for kill claims against SARS-CoV-2, the novel coronavirus that causes COVID-19, on hard non-porous surfaces. The new multi-purpose disinfectant and cleaner has been added to the EPA’s List N under EPA Reg No. 91691-1.

Getinge Expands Vascular Surgery Business

Getinge is investing 3 million Euros in its manufacturing of polyester grafts and patches to treat aneurysmal and occlusive diseases. The investment aims at increasing manufacturing capacity in Getinge’s site in La Ciotat, France.

Getinge has more than 50 years of technical and clinical experience in vascular graft technology and is today one of the leading manufacturers worldwide within this segment.

“We have seen a growing demand from our customers for our vascular grafts portfolio and in order to meet this demand we will expand our facility area and equipment,” says Jocelyn Lebrun, Managing Director Getinge La Ciotat. “We also estimate that the investment will lead to an increased need for additional personnel, primarily within engineering and manufacturing.”

Today the La Ciotat site employs 270 employees and has 6000 m2 facility area including 2 clean rooms for a total of 900 m2.

“The site produces approximately 230,000 units per year, which is estimated to support saving 500 lives per day”, Jocelyn Lebrun continues. “We expect the facility expansion to be ready and operational within the coming years. In the meantime, we will increase our production by adding shifts to help fulfill customer needs”.

Learn more about Getinge’s vascular systems on the website: www.getinge.com/int/products/hospital/vascular-and-cardiothoracic-surgery-solutions/.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X